Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001386-34Phase 3Completed
Phase 3, randomised, double-blind trial in asthma comparing Ciclesonide arm, Fluticasone propionate arm and Placebo arm (3 arms). Primary endpoints: Short-term linear growth rate and HPA-axis function. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001386-34.